PHESGO® is a subcutaneous combination of pertuzumab and trastuzumab for HER2-positive breast cancer, designed to reduce treatment time.
Related products
Ozempic 0.25mg Injection (UK)
Semaglutide
Wegovy 1mg/0.5ml Inj. x 1Pen
Semaglutide Injection
Wegovy 7.2mg/0.75ml Prefilled Inj. x 4 Pens (UK)
Zoladex 10.8mg Inj. x 1 (NAFDAC)
Wegovy 0.25mg/0.5ml Inj. x 1Pen
Semaglutide Injection

















